Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.39 USD | +2.73% | -7.30% | +127.36% |
05-02 | Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+127.36% | 148M | |
+70.03% | 62.86B | |
-0.81% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.28% | 26.46B | |
-22.52% | 18.9B | |
+4.85% | 12.67B | |
+24.14% | 12.27B | |
+28.05% | 12.07B |
- Stock Market
- Equities
- CRDF Stock
- News Cardiff Oncology, Inc.
- Cardiff Oncology Chief Medical Officer Katherine Ruffner to Depart